Back
GlycoMimetics Vs. Arbutus Biopharma Industry Stock Comparison
Buy
73
GLYC
GlycoMimetics
Last Price:
0.41
Seasonality Move:
59.04%
Buy
51
ABUS
Arbutus Biopharma
Last Price:
3.87
Seasonality Move:
20.32%
Buy
73
GlycoMimetics (GLYC)
is a Buy
Is GlycoMimetics a Buy, Sell or Hold?
- The current GlycoMimetics [GLYC] share price is $0.41. The Score for GLYC is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- GLYC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Arbutus Biopharma (ABUS)
is a Buy
Is Arbutus Biopharma a Buy, Sell or Hold?
- The current Arbutus Biopharma [ABUS] share price is $3.86. The Score for ABUS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ABUS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GLYC Stock Price Chart
What is GlycoMimetics's stock price today?
-
The GlycoMimetics share price today is $0.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GLYC is experiencing buying pressure, which is a positive indicator for future bullish movement.
ABUS Stock Price Chart
What is Arbutus Biopharma's stock price today?
-
The Arbutus Biopharma share price today is $3.86
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.
GLYC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 72.13 | Buy |
Chaikin Money Flow: | 3598184 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.1 - 0.32) | Buy |
Bollinger Bands (100): | (0.15 - 0.29) | Buy |
ABUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 43.93 | Sell |
Chaikin Money Flow: | -767949 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.81 - 4.07) | Sell |
Bollinger Bands (100): | (3.39 - 4.15) | Buy |
GLYC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.33 | Buy |
20-day SMA: | 0.23 | Buy |
50-day SMA: | 0.19 | Buy |
200-day SMA: | 1.15 | Sell |
8-day EMA: | 0.35 | Buy |
20-day EMA: | 0.27 | Buy |
50-day EMA: | 0.23 | Buy |
200-day EMA: | 0.79 | Sell |
ABUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.96 | Sell |
20-day SMA: | 3.96 | Sell |
50-day SMA: | 4.03 | Sell |
200-day SMA: | 3.29 | Buy |
8-day EMA: | 3.95 | Sell |
20-day EMA: | 3.97 | Sell |
50-day EMA: | 3.94 | Sell |
200-day EMA: | 3.4 | Buy |
GlycoMimetics Earnings Growth & GLYC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.01 per share.
Arbutus Biopharma Earnings Growth & ABUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
GlycoMimetics Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Arbutus Biopharma Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |